Scar-driven changes in joint tissue may underlie treatment resistance in rheumatoid arthritis, opening the door to new targeted therapies.
A detailed “tissue map” of rheumatoid arthritis joints suggests that scarring pathway, not just immune inflammation, may help explain why some patients don’t respond to standard therapies. Credit: Sh… [+6638 chars]